Biomerica, Inc.
BMRA
$2.71
-$0.08-2.87%
NASDAQ
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 84.25% | -33.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 84.25% | -33.07% | |||
| Cost of Revenue | -3.73% | -9.73% | |||
| Gross Profit | 273.77% | -1,384.21% | |||
| SG&A Expenses | 24.53% | 5.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.00% | -0.69% | |||
| Operating Income | 28.52% | -29.26% | |||
| Income Before Tax | 100.32% | -31.88% | |||
| Income Tax Expenses | -40.00% | 225.00% | |||
| Earnings from Continuing Operations | 100.13% | -32.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 100.13% | -32.76% | |||
| EBIT | 28.52% | -29.26% | |||
| EBITDA | 28.75% | -29.60% | |||
| EPS Basic | 100.11% | -44.28% | |||
| Normalized Basic EPS | 100.28% | -43.34% | |||
| EPS Diluted | 100.11% | -50.51% | |||
| Normalized Diluted EPS | 100.28% | -43.34% | |||
| Average Basic Shares Outstanding | 19.57% | -7.98% | |||
| Average Diluted Shares Outstanding | 19.57% | -7.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||